title: Magnetic resonance imaging and pituitary function in children with panhypopituitarism.
abstract: BACKGROUND
  To explore the relationship between magnetic resonance imaging (MRI) findings and multiple pituitary-target hormones in patients with panhypopituitarism or multiple pituitary hormone deficiency (MPHD).
  
  
  METHODS
  125 patients with MPHD (102 boys, MPHD group) and 90 age-, sex- and Tanner stage-matched normal children (control group) were enrolled. 96 of the patients with MPHD underwent MRI scans of the hypothalamic-pituitary area. The patients were subdivided into five stages according to their MRI findings. The serum concentrations of GH, IGF-1, FT(4), TSH, ACTH, cortisol, FSH, LH, prolactin, testosterone and estradiol were measured in patients and in controls.
  
  
  RESULTS
  MRI stage was significantly positively correlated with the number of pituitary hormone deficiencies (r = 0.9, p < 0.001). MRI stage was negatively correlated with peak GH, IGF-1, FT(4), cortisol and anterior pituitary height (r = -0.43, -0.47, -0.67, -0.54, and -0.49, respectively, p < 0.01). Diabetes insipidus patients could be stratified according to their MRI stage; diabetes insipidus was found mainly in patients with absence of the posterior pituitary bright spot or small ectopic posterior pituitary bright spot on MRI.
  
  
  CONCLUSIONS
  An abnormal MRI finding is evidence of MPHD and, correspondingly, there is a noteworthy correlation between MRI and pituitary function.
authors.affiliation: Pediatric Department, Provincial Hospital Affiliated to Shandong University, Shandong, PR China. lgmusa05@yahoo.com
authors.forename: Guimei
authors.initials: G
authors.lastname: Li
authors.forename: Peng
authors.initials: P
authors.lastname: Shao
authors.forename: Xiaojun
authors.initials: X
authors.lastname: Sun
authors.forename: Qian
authors.initials: Q
authors.lastname: Wang
authors.forename: Lijuan
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D001120:Arginine; D002648:Child; D005260:Female; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D007018:Hypopituitarism / Q000473:pathology* / Q000503:physiopathology*; D007328:Insulin; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007980:Levodopa; D008279:Magnetic Resonance Imaging; D008297:Male; D010902:Pituitary Gland / Q000473:pathology / Q000503:physiopathology*; D010907:Pituitary Hormones / Q000172:deficiency*
chemical_list: D007328:Insulin; D010907:Pituitary Hormones; D019382:Human Growth Hormone; D007980:Levodopa; D007334:Insulin-Like Growth Factor I; D001120:Arginine